Search clinical trials for: B-cell Activating Factor
Total 38023 results
-
National Cancer Institute (NCI)CompletedBurkitt Lymphoma | Plasmablastic Lymphoma | Diffuse Large B-cell Lymphoma, c-MYC PositiveUnited States
-
Seoul National University HospitalCompletedNon-hodgkin Lymphoma,B CellKorea, Republic of
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan
-
Genentech, Inc.TerminatedMultiple Myeloma | Non-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Korea, Republic of
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
The First Affiliated Hospital of Soochow UniversityEnrolling by invitationRelapsed or Refractory B-cell Non-Hodgkin LymphomaChina
-
Abramson Cancer Center at Penn MedicineCompletedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid TissueUnited States
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; PharmatechCompleted
-
Sarit AssoulineNovartis; Hoffmann-La Roche; Quebec Clinical Research Organization in CancerCompletedDiffuse Large B Cell LymphomaCanada
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
TCR2 TherapeuticsCompletedFollicular Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell LymphomaUnited States
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
Genentech, Inc.CompletedLymphoma, Non HodgkinUnited States, France
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingLarge B-cell Diffuse Lymphoma of TestisItaly, Switzerland
-
Hoffmann-La RocheTerminated
-
Shanghai Pudong HospitalUTC Therapeutics Inc.WithdrawnAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | B-cell Non-Hodgkin's Lymphoma (B-NHL) | T-Cell Leukemia/Lymphoma, Adult | B-cell Acute Lymphoblastic Leukemia (B-ALL)China
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingFollicular Lymphoma | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Bone Marrow Failure Syndromes | Burkitt's Lymphoma | Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
Federal Research Institute of Pediatric Hematology...Active, not recruitingB-cell Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia, PediatricRussian Federation
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | NHL | High-grade B-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Indolent Adult Non-Hodgkin LymphomaUnited States
-
Cartesian TherapeuticsActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...Enrolling by invitationDiffuse Large B-cell LymphomaChina
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Second Affiliated Hospital of Soochow UniversityEnrolling by invitationDiffuse Large B-cell LymphomaChina
-
Fred Hutchinson Cancer CenterADC TherapeuticsWithdrawnRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent High... and other conditionsUnited States
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
University of MichiganCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Ruijin HospitalActive, not recruiting
-
Janssen Research & Development, LLCPharmacyclics LLC.TerminatedLymphoma, Non-HodgkinUnited States, France, Poland, United Kingdom, Germany, Taiwan, Spain, Bulgaria, Romania, Turkey, Ukraine, Canada, Korea, Republic of, Netherlands, Russian Federation, Belgium, Brazil, Hungary, Czechia, Sweden
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent... and other conditionsUnited States
-
Molly GalloglyActive, not recruitingDiffuse Large B-cell-lymphomaUnited States
-
Hoffmann-La RocheCompletedLymphomaUnited States, Italy, Korea, Republic of, Australia, Canada, Czechia, Spain, United Kingdom, France, Germany, Hungary, Turkey, Netherlands
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Fogarty...CompletedHIV | Diffuse Large B-cell LymphomaMalawi
-
New York Medical CollegeCompletedDiffuse Large Cell Lymphoma | Burkitt's Lymphoma | High Grade B-cell LymphomaUnited States
-
Hackensack Meridian HealthJanssen Scientific Affairs, LLC; Genentech, Inc.Active, not recruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma | Hodgkin LymphomaUnited States
-
Yazeed SawalhaWithdrawnRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
-
Rush University Medical CenterTerminatedDiffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Brian HillThe Cleveland ClinicTerminatedLymphoma | B Cell LymphomaUnited States
-
Joshua BrodyCelldex TherapeuticsCompletedLow-Grade B-cell LymphomaUnited States
-
University of MiamiAstraZenecaTerminatedMarginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune...TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedUnited States
-
Weill Medical College of Cornell UniversityM.D. Anderson Cancer Center; Massachusetts General Hospital; Genentech, Inc.CompletedDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States